Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sorio

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Tumori|May 7, 2002
Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case reportA Bearz, B Giometto, A Freschi, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tractA Veronesi, E Galligioni, G Lo Re, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 24, 2007
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancerM O Nicoletto, S Tumolo, R Sorio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 16, 2011
Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trialG Giorda, G Boz, A Gadducci, et al.
Anti-Cancer Drugs|June 1, 1995
Effect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancerM Gigante, R Sorio, A M Colussi, et al.
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoringD Crivellari, D Lombardi, G Corona, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapyS Pignata, F Amant, G Scambia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiformeC Twelves, M Campone, B Coudert, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)N Pavlidis, S Aamdal, A Awada, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Tumori|May 7, 2002
Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case reportA Bearz, B Giometto, A Freschi, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tractA Veronesi, E Galligioni, G Lo Re, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 24, 2007
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancerM O Nicoletto, S Tumolo, R Sorio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 16, 2011
Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trialG Giorda, G Boz, A Gadducci, et al.
Anti-Cancer Drugs|June 1, 1995
Effect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancerM Gigante, R Sorio, A M Colussi, et al.
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoringD Crivellari, D Lombardi, G Corona, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapyS Pignata, F Amant, G Scambia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiformeC Twelves, M Campone, B Coudert, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)N Pavlidis, S Aamdal, A Awada, et al.
Pageof 6